Current
$195.21B
5-Year Average
$338.14B
All-Time High
$656.76B
All-Time Low
$15.89B
Market cap daily chart for Novo Nordisk (NVO)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap history table for Novo Nordisk (NVO) from 1985 to 2026
| 2026 | — | — | — | ||
| 2025 | — | — | — | ||
| 2024 | — | — | — | ||
| 2023 | — | — | — | ||
| 2022 | — | — | — | ||
| 2021 | — | — | — | ||
| 2020 | — | — | — | ||
| 2019 | — | — | — | ||
| 2018 | — | — | — | ||
| 2017 | — | — | — | ||
| 2016 | — | — | — | ||
| 2015 | — | — | — | ||
| 2014 | — | — | — | ||
| 2013 | — | — | — | ||
| 2012 | — | — | — | ||
| 2011 | — | — | — | ||
| 2010 | — | — | — | ||
| 2009 | — | — | — | ||
| 2008 | — | — | — | ||
| 2007 | — | — | — | ||
| 2006 | — | — | — | ||
| 2005 | — | — | — | ||
| 2004 | — | — | — | ||
| 2003 | — | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2026——
- 2025——
- 2024——
- 2023——
- 2022——
- 2021——
- 2020——
- 2019——
- 2018——
- 2017——
- 2016——
- 2015——
- 2014——
- 2013——
- 2012——
- 2011——
- 2010——
- 2009——
- 2008——
- 2007——
- 2006——
- 2005——
- 2004——
- 2003——
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
Market Cap values are taken from Novo Nordisk's reported income statements (share counts) and end-of-day prices (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Market Cap at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported market cap is $163.49B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Novo Nordisk (NVO) market cap totalled $195.21B – declined 13.7% year-over-year.
Over 2021–2026 (5 years), Novo Nordisk market cap expanded at a -5.4% compound annual rate, with a net decline across the window.
Novo Nordisk market cap peaked at $464.99B in 2023; the latest annual figure is $195.21B in 2026 (58.0% below peak).
$464.99B stands as the all-time-high annual market cap, posted in 2023, against a low of $543.36M during 1987.
Novo Nordisk Market Cap by Year
Novo Nordisk Market Cap 2026: $195.21B
2026's market cap for Novo Nordisk came in at $195.21B, declined 13.7% below 2025.
Novo Nordisk Market Cap 2025: $226.31B
Novo Nordisk posted market cap of $226.31B in 2025, plunged 41.1% below 2024.
Novo Nordisk Market Cap 2024: $383.91B
In 2024, Novo Nordisk reported market cap of $383.91B, declined 17.4% below 2023.
Novo Nordisk Market Cap 2023: $464.99B
Novo Nordisk market cap in 2023 was $464.99B, surged 51.2% from 2022. This figure represents the highest annual value in the available history.
Novo Nordisk Market Cap 2022: $307.53B
Novo Nordisk market cap in 2022 was $307.53B.
See more financial history for Novo Nordisk (NVO).
Sector peers by Market Cap
Healthcare peers of Novo Nordisk (NVO), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $191.70B | |
| $174.42B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $191.70B
- $174.42B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation